CORT vs. COST

Last updated Apr 1, 2026

Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST).

Performance

CORT vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

CORT vs. COST - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CORT Corcept Therapeutics Incorporated	15.83%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%
COST Costco Wholesale Corporation	15.71%	-5.39%	39.62%	49.00%	-19.05%	51.82%	32.67%	45.70%	10.60%	22.37%

Fundamentals

EPS CORT : $0.88 COST : $25.63
PE Ratio CORT : 45.97 COST : 38.87
PEG Ratio CORT : 22.90 COST : 3.04
PS Ratio CORT : 6.52 COST : 1.16
Total Revenue (TTM) CORT : $741.17M COST : $286.27B
Gross Profit (TTM) CORT : $727.78M COST : $19.33B
EBITDA (TTM) CORT : $72.46M COST : $12.73B

Returns By Period

The year-to-date returns for both stocks are quite close, with CORT having a 15.83% return and COST slightly lower at 15.71%. Over the past 10 years, CORT has outperformed COST with an annualized return of 23.92%, while COST has yielded a comparatively lower 22.28% annualized return.

CORT

• 1D: 5.75%
• 1M: 12.91%
• YTD: 15.83%
• 6M: -51.50%
• 1Y: -64.71%
• 3Y*: 23.00%
• 5Y*: 10.53%
• 10Y*: 23.92%

COST

• 1D: -0.02%
• 1M: -1.42%
• YTD: 15.71%
• 6M: 7.95%
• 1Y: 5.93%
• 3Y*: 27.83%
• 5Y*: 24.28%
• 10Y*: 22.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CORT vs. COST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT

CORT Risk / Return Rank: 18
CORT Sharpe Ratio Rank: 8
CORT Sortino Ratio Rank: 12
CORT Omega Ratio Rank: 7
CORT Calmar Ratio Rank: 31
CORT Martin Ratio Rank: 33

COST

COST Risk / Return Rank: 49
COST Sharpe Ratio Rank: 53
COST Sortino Ratio Rank: 45
COST Omega Ratio Rank: 44
COST Calmar Ratio Rank: 52
COST Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CORT vs. COST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CORT	COST	Difference
Sharpe ratio Return per unit of total volatility	-0.82	0.30	-1.12
Sortino ratio Return per unit of downside risk	-0.96	0.57	-1.53
Omega ratio Gain probability vs. loss probability	0.82	1.07	-0.25
Calmar ratio Return relative to maximum drawdown	-0.36	0.40	-0.77
Martin ratio Return relative to average drawdown	-0.58	0.80	-1.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CORT vs. COST - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is -0.82, which is lower than the COST Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of CORT and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CORT	COST	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.82	0.30	-1.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	1.08	-0.94
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.36	1.02	-0.66
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.59	-0.52

Correlation

The correlation between CORT and COST is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CORT vs. COST - Dividend Comparison

CORT has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.52%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CORT Corcept Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
COST Costco Wholesale Corporation	0.52%	0.59%	0.49%	2.87%	0.76%	0.54%	3.38%	0.86%	1.08%	4.81%	1.09%	4.06%

Drawdowns

CORT vs. COST - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for CORT and COST.

Drawdown Indicators

	CORT	COST	Difference
Max Drawdown Largest peak-to-trough decline	-94.28%	-53.39%	-40.89%
Max Drawdown (1Y) Largest decline over 1 year	-65.03%	-19.35%	-45.68%
Max Drawdown (5Y) Largest decline over 5 years	-71.85%	-31.40%	-40.45%
Max Drawdown (10Y) Largest decline over 10 years	-71.85%	-31.40%	-40.45%
Current Drawdown Current decline from peak	-64.71%	-6.96%	-57.75%
Average Drawdown Average peak-to-trough decline	-53.45%	-13.40%	-40.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	45.10%	9.67%	+35.43%

Volatility

CORT vs. COST - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 21.99% compared to Costco Wholesale Corporation (COST) at 4.41%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CORT	COST	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.99%	4.41%	+17.58%
Volatility (6M) Calculated over the trailing 6-month period	85.27%	13.36%	+71.91%
Volatility (1Y) Calculated over the trailing 1-year period	134.82%	20.15%	+114.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	73.97%	22.51%	+51.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	67.09%	21.90%	+45.19%

Financials

CORT vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between Corcept Therapeutics Incorporated and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported a gross profit of 203.04M and revenue of 207.64M. Therefore, the gross margin over that period was 97.8%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported a gross profit of -8.80B and revenue of 69.60B. Therefore, the gross margin over that period was -12.6%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported an operating income of 10.22M and revenue of 207.64M, resulting in an operating margin of 4.9%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported an operating income of 2.61B and revenue of 69.60B, resulting in an operating margin of 3.7%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Corcept Therapeutics Incorporated reported a net income of 19.36M and revenue of 207.64M, resulting in a net margin of 9.3%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported a net income of 2.04B and revenue of 69.60B, resulting in a net margin of 2.9%.